A Study of CDX-622 in Participants With Mild to Moderate Asthma

Recruiting

Phase 1

CDX-622A Study of CDX-622 in Participants With Mild to Moderate Asthma

Sponsor:

Celldex Therapeutics

Code:

NCT07330778

Conditions

Mild to Moderate Asthma

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

CDX-622

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2026-02-01. This information was provided to ClinicalTrials.gov by Celldex Therapeutics on 2026-01-22.